APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iguratimod

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Iguratimod Industry Growth and Trends Forecast to 2032

23 December 202573 pages

Choose your research edition.

Industry ResearchIguratimod Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Iguratimod Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Iguratimod Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iguratimod Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Iguratimod Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Iguratimod market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Iguratimod is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Iguratimod is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iguratimod is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Iguratimod include Simcere Pharmaceutical, Eisai and Toyama Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Iguratimod market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Iguratimod market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Iguratimod market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Iguratimod.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Iguratimod market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Iguratimod Market by Company

Simcere Pharmaceutical

Eisai

Toyama Chemical

Iguratimod Segment by Type

14 Pcs/Box

100 Pcs/Box

Iguratimod Segment by Application

Antirheumatic

Immunoregulation

Others

Iguratimod Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iguratimod market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iguratimod and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iguratimod.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Iguratimod manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Iguratimod in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 14 Pcs/Box Table 2. Major Company of 100 Pcs/Box Table 3. Global Iguratimod Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Iguratimod Sales by Type (2021-2026) & (k pcs) Table 5. Global Iguratimod Sales Market Share in Volume by Type (2021-2026) Table 6. Global Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 7. Global Iguratimod Sales Market Share in Value by Type (2021-2026) Table 8. Global Iguratimod Price by Type (2021-2026) & (US$/pcs) Table 9. Global Iguratimod Sales by Type (2027-2032) & (k pcs) Table 10. Global Iguratimod Sales Market Share in Volume by Type (2027-2032) Table 11. Global Iguratimod Sales by Type (2027-2032) & (US$ Million) Table 12. Global Iguratimod Sales Market Share in Value by Type (2027-2032) Table 13. Global Iguratimod Price by Type (2027-2032) & (US$/pcs) Table 14. North America Iguratimod Sales by Type (2021-2026) & (k pcs) Table 15. North America Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Iguratimod Sales by Type (2021-2026) & (k pcs) Table 17. Europe Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Iguratimod Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Iguratimod Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Iguratimod Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Iguratimod Sales by Type (2021-2026) & (US$ Million) Table 24. Iguratimod Industry Trends Table 25. Iguratimod Industry Drivers Table 26. Iguratimod Industry Opportunities and Challenges Table 27. Iguratimod Industry Restraints Table 28. Global Iguratimod Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Iguratimod Revenue Market Share by Company (2021-2026) Table 30. Global Iguratimod Sales by Company (2021-2026) & (k pcs) Table 31. Global Iguratimod Sales Share by Company (2021-2026) Table 32. Global Iguratimod Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Iguratimod Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Iguratimod Major Company Production Sites and Headquarters Table 35. Global Iguratimod Company, Product Type & Application Table 36. Global Iguratimod Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Iguratimod by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Iguratimod Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Iguratimod Sales by Region (2021-2026) & (k pcs) Table 41. Global Iguratimod Sales Market Share in Volume by Region (2021-2026) Table 42. Global Iguratimod Sales by Region (2021-2026) & (US$ Million) Table 43. Global Iguratimod Sales Market Share in Value by Region (2021-2026) Table 44. Global Iguratimod Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Iguratimod Sales by Region (2027-2032) & (k pcs) Table 46. Global Iguratimod Sales Market Share in Volume by Region (2027-2032) Table 47. Global Iguratimod Sales by Region (2027-2032) & (US$ Million) Table 48. Global Iguratimod Sales Market Share in Value by Region (2027-2032) Table 49. Global Iguratimod Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Iguratimod Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Iguratimod Sales by Application (2021-2026) & (k pcs) Table 52. Global Iguratimod Sales Market Share in Volume by Application (2021-2026) Table 53. Global Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 54. Global Iguratimod Sales Market Share in Value by Application (2021-2026) Table 55. Global Iguratimod Price by Application (2021-2026) & (US$/pcs) Table 56. Global Iguratimod Sales by Application (2027-2032) & (k pcs) Table 57. Global Iguratimod Sales Market Share in Volume by Application (2027-2032) Table 58. Global Iguratimod Sales by Application (2027-2032) & (US$ Million) Table 59. Global Iguratimod Sales Market Share in Value by Application (2027-2032) Table 60. Global Iguratimod Price by Application (2027-2032) & (US$/pcs) Table 61. North America Iguratimod Sales by Application (2021-2026) & (k pcs) Table 62. North America Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Iguratimod Sales by Application (2021-2026) & (k pcs) Table 64. Europe Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Iguratimod Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Iguratimod Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Iguratimod Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Iguratimod Sales by Application (2021-2026) & (US$ Million) Table 71. Simcere Pharmaceutical Company Information Table 72. Simcere Pharmaceutical Business Overview Table 73. Simcere Pharmaceutical Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Simcere Pharmaceutical Iguratimod Product Portfolio Table 75. Simcere Pharmaceutical Recent Development Table 76. Eisai Company Information Table 77. Eisai Business Overview Table 78. Eisai Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Eisai Iguratimod Product Portfolio Table 80. Eisai Recent Development Table 81. Toyama Chemical Company Information Table 82. Toyama Chemical Business Overview Table 83. Toyama Chemical Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Toyama Chemical Iguratimod Product Portfolio Table 85. Toyama Chemical Recent Development Table 86. North America Iguratimod Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 87. North America Iguratimod Sales by Country (2021-2026) & (k pcs) Table 88. North America Iguratimod Sales Market Share by Country (2021-2026) Table 89. North America Iguratimod Sales Forecast by Country (2027-2032) & (k pcs) Table 90. North America Iguratimod Sales Market Share Forecast by Country (2027-2032) Table 91. North America Iguratimod Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Iguratimod Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Iguratimod Market Share by Country (2021-2026) Table 94. North America Iguratimod Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Iguratimod Market Share Forecast by Country (2027-2032) Table 96. Europe Iguratimod Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 97. Europe Iguratimod Sales by Country (2021-2026) & (k pcs) Table 98. Europe Iguratimod Sales Market Share by Country (2021-2026) Table 99. Europe Iguratimod Sales Forecast by Country (2027-2032) & (k pcs) Table 100. Europe Iguratimod Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Iguratimod Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Iguratimod Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Iguratimod Market Share by Country (2021-2026) Table 104. Europe Iguratimod Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Iguratimod Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Iguratimod Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Iguratimod Sales by Country (2021-2026) & (k pcs) Table 108. Asia-Pacific Iguratimod Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Iguratimod Sales Forecast by Country (2027-2032) & (k pcs) Table 110. Asia-Pacific Iguratimod Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Iguratimod Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Iguratimod Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Iguratimod Market Share by Country (2021-2026) Table 114. Asia-Pacific Iguratimod Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Iguratimod Market Share Forecast by Country (2027-2032) Table 116. Latin America Iguratimod Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 117. Latin America Iguratimod Sales by Country (2021-2026) & (k pcs) Table 118. Latin America Iguratimod Sales Market Share by Country (2021-2026) Table 119. Latin America Iguratimod Sales Forecast by Country (2027-2032) & (k pcs) Table 120. Latin America Iguratimod Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Iguratimod Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Iguratimod Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Iguratimod Market Share by Country (2021-2026) Table 124. Latin America Iguratimod Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Iguratimod Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Iguratimod Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Iguratimod Sales by Country (2021-2026) & (k pcs) Table 128. Middle East and Africa Iguratimod Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Iguratimod Sales Forecast by Country (2027-2032) & (k pcs) Table 130. Middle East and Africa Iguratimod Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Iguratimod Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Iguratimod Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Iguratimod Market Share by Country (2021-2026) Table 134. Middle East and Africa Iguratimod Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Iguratimod Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Iguratimod Distributors List Table 139. Iguratimod Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Iguratimod Image Figure 2. Global Iguratimod Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iguratimod Market Size (2021-2032) & (US$ Million) Figure 4. Global Iguratimod Sales (2021-2032) & (k pcs) Figure 5. 14 Pcs/Box Image Figure 6. Global 14 Pcs/Box Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 100 Pcs/Box Image Figure 8. Global 100 Pcs/Box Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Iguratimod Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Iguratimod Market Share by Type 2025 VS 2032 Figure 11. North America Iguratimod Sales Market Share in Volume by Type in 2025 Figure 12. North America Iguratimod Sales Market Share in Value by Type in 2025 Figure 13. Europe Iguratimod Sales Market Share in Volume by Type in 2025 Figure 14. Europe Iguratimod Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Iguratimod Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Iguratimod Sales Market Share in Value by Type in 2025 Figure 17. Latin America Iguratimod Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Iguratimod Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Iguratimod Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Iguratimod Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Iguratimod Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Antirheumatic Image Figure 24. Global Antirheumatic Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Immunoregulation Image Figure 26. Global Immunoregulation Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Global Iguratimod Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Iguratimod Market Share by Application 2025 VS 2032 Figure 31. North America Iguratimod Sales Market Share in Volume by Application in 2025 Figure 32. North America Iguratimod Sales Market Share in Value by Application in 2025 Figure 33. Europe Iguratimod Sales Market Share in Volume by Application in 2025 Figure 34. Europe Iguratimod Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Iguratimod Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Iguratimod Sales Market Share in Value by Application in 2025 Figure 37. Latin America Iguratimod Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Iguratimod Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Iguratimod Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Iguratimod Sales Market Share in Value by Application in 2025 Figure 41. North America Iguratimod Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 42. North America Iguratimod Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Iguratimod Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Iguratimod Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Iguratimod Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 46. Europe Iguratimod Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Iguratimod Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Iguratimod Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Iguratimod Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 50. Asia-Pacific Iguratimod Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Iguratimod Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Iguratimod Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Iguratimod Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 54. Latin America Iguratimod Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Iguratimod Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Iguratimod Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Iguratimod Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 58. Middle East and Africa Iguratimod Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Iguratimod Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Iguratimod Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Iguratimod Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Iguratimod Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Pcs/Box
  • 100 Pcs/Box
Applications
  • Antirheumatic
  • Immunoregulation
  • Others
Companies covered
  • Simcere Pharmaceutical
  • Eisai
  • Toyama Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iguratimod Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Iguratimod Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Iguratimod Market by Type
  6. 1.3.1 14 Pcs/Box
  7. 1.3.2 100 Pcs/Box
  8. 1.4 Global Iguratimod Market Size by Type
  9. 1.4.1 Global Iguratimod Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Iguratimod Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Iguratimod Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Iguratimod Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Iguratimod Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Iguratimod Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Iguratimod Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Iguratimod Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Iguratimod Industry Trends
  2. 2.2 Iguratimod Industry Drivers
  3. 2.3 Iguratimod Industry Opportunities and Challenges
  4. 2.4 Iguratimod Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Iguratimod Revenue (2021-2026)
  2. 3.2 Global Top Players by Iguratimod Sales (2021-2026)
  3. 3.3 Global Top Players by Iguratimod Price (2021-2026)
  4. 3.4 Global Iguratimod Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Iguratimod Major Company Production Sites & Headquarters
  6. 3.6 Global Iguratimod Company, Product Type & Application
  7. 3.7 Global Iguratimod Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Iguratimod Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Iguratimod Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Iguratimod Tier 1, Tier 2, and Tier 3
4 Iguratimod Regional Status and Outlook
  1. 4.1 Global Iguratimod Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Iguratimod Historic Market Size by Region
  3. 4.2.1 Global Iguratimod Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Iguratimod Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Iguratimod Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Iguratimod Forecasted Market Size by Region
  7. 4.3.1 Global Iguratimod Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Iguratimod Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Iguratimod Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Iguratimod by Application
  1. 5.1 Iguratimod Market by Application
  2. 5.1.1 Antirheumatic
  3. 5.1.2 Immunoregulation
  4. 5.1.3 Others
  5. 5.2 Global Iguratimod Market Size by Application
  6. 5.2.1 Global Iguratimod Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Iguratimod Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Iguratimod Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Iguratimod Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Iguratimod Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Iguratimod Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Iguratimod Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Iguratimod Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Simcere Pharmaceutical
  2. 6.1.1 Simcere Pharmaceutical Company Information
  3. 6.1.2 Simcere Pharmaceutical Business Overview
  4. 6.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Simcere Pharmaceutical Iguratimod Product Portfolio
  6. 6.1.5 Simcere Pharmaceutical Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Iguratimod Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Iguratimod Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Toyama Chemical
  14. 6.3.1 Toyama Chemical Company Information
  15. 6.3.2 Toyama Chemical Business Overview
  16. 6.3.3 Toyama Chemical Iguratimod Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Toyama Chemical Iguratimod Product Portfolio
  18. 6.3.5 Toyama Chemical Recent Developments
7 North America by Country
  1. 7.1 North America Iguratimod Sales by Country
  2. 7.1.1 North America Iguratimod Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Iguratimod Sales by Country (2021-2026)
  4. 7.1.3 North America Iguratimod Sales Forecast by Country (2027-2032)
  5. 7.2 North America Iguratimod Market Size by Country
  6. 7.2.1 North America Iguratimod Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Iguratimod Market Size by Country (2021-2026)
  8. 7.2.3 North America Iguratimod Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Iguratimod Sales by Country
  2. 8.1.1 Europe Iguratimod Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Iguratimod Sales by Country (2021-2026)
  4. 8.1.3 Europe Iguratimod Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Iguratimod Market Size by Country
  6. 8.2.1 Europe Iguratimod Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Iguratimod Market Size by Country (2021-2026)
  8. 8.2.3 Europe Iguratimod Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Iguratimod Sales by Country
  2. 9.1.1 Asia-Pacific Iguratimod Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Iguratimod Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Iguratimod Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Iguratimod Market Size by Country
  6. 9.2.1 Asia-Pacific Iguratimod Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Iguratimod Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Iguratimod Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Iguratimod Sales by Country
  2. 10.1.1 South America Iguratimod Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Iguratimod Sales by Country (2021-2026)
  4. 10.1.3 South America Iguratimod Sales Forecast by Country (2027-2032)
  5. 10.2 South America Iguratimod Market Size by Country
  6. 10.2.1 South America Iguratimod Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Iguratimod Market Size by Country (2021-2026)
  8. 10.2.3 South America Iguratimod Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Iguratimod Sales by Country
  2. 11.1.1 Middle East and Africa Iguratimod Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Iguratimod Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Iguratimod Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Iguratimod Market Size by Country
  6. 11.2.1 Middle East and Africa Iguratimod Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Iguratimod Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Iguratimod Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Iguratimod Value Chain Analysis
  2. 12.1.1 Iguratimod Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Iguratimod Production Mode & Process
  7. 12.2 Iguratimod Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Iguratimod Distributors
  10. 12.2.3 Iguratimod Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst